annual interest expense:
$13.44M-$3.87M(-22.36%)Summary
- As of today (July 1, 2025), PCRX annual interest expense is $13.44 million, with the most recent change of -$3.87 million (-22.36%) on December 31, 2024.
- During the last 3 years, PCRX annual interest expense has fallen by -$15.56 million (-53.65%).
- PCRX annual interest expense is now -62.22% below its all-time high of $35.58 million, reached on December 31, 2022.
Performance
PCRX Interest expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly interest expense:
$3.73M-$99.00K(-2.58%)Summary
- As of today (July 1, 2025), PCRX quarterly interest expense is $3.73 million, with the most recent change of -$99.00 thousand (-2.58%) on March 31, 2025.
- Over the past year, PCRX quarterly interest expense has increased by +$1.10 million (+41.75%).
- PCRX quarterly interest expense is now -61.28% below its all-time high of $9.64 million, reached on December 31, 2021.
Performance
PCRX quarterly interest expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM interest expense:
$14.54M+$1.10M(+8.19%)Summary
- As of today (July 1, 2025), PCRX TTM interest expense is $14.54 million, with the most recent change of +$1.10 million (+8.19%) on March 31, 2025.
- Over the past year, PCRX TTM interest expense has increased by +$3.25 million (+28.74%).
- PCRX TTM interest expense is now -59.19% below its all-time high of $35.62 million, reached on September 30, 2022.
Performance
PCRX TTM interest expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Interest expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
PCRX Interest expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -22.4% | +41.8% | +28.7% |
| 3 y3 years | -53.6% | -58.8% | -54.2% |
| 5 y5 years | -38.7% | -33.1% | -32.9% |
PCRX Interest expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -62.2% | at low | -61.1% | +41.8% | -59.2% | +29.4% |
| 5 y | 5-year | -62.2% | at low | -61.3% | +41.8% | -59.2% | +29.4% |
| alltime | all time | -62.2% | +643.7% | -61.3% | +988.9% | -59.2% | +2986.8% |
PCRX Interest expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $3.73M(-2.6%) | $14.54M(+8.2%) |
| Dec 2024 | $13.44M(-22.4%) | $3.83M(-0.4%) | $13.44M(+9.2%) |
| Sep 2024 | - | $3.85M(+23.3%) | $12.31M(+9.5%) |
| Jun 2024 | - | $3.12M(+18.4%) | $11.24M(-0.5%) |
| Mar 2024 | - | $2.63M(-2.5%) | $11.29M(-34.8%) |
| Dec 2023 | $17.31M(-51.3%) | $2.70M(-2.8%) | $17.31M(-28.5%) |
| Sep 2023 | - | $2.78M(-12.4%) | $24.20M(-20.3%) |
| Jun 2023 | - | $3.17M(-63.3%) | $30.38M(-13.6%) |
| Mar 2023 | - | $8.65M(-9.8%) | $35.16M(-1.2%) |
| Dec 2022 | $35.58M(+22.7%) | $9.60M(+7.2%) | $35.58M(-0.1%) |
| Sep 2022 | - | $8.95M(+12.5%) | $35.62M(+6.9%) |
| Jun 2022 | - | $7.96M(-12.2%) | $33.34M(+5.0%) |
| Mar 2022 | - | $9.07M(-6.0%) | $31.74M(+9.5%) |
| Dec 2021 | $29.00M(+23.3%) | $9.64M(+44.7%) | $29.00M(+12.5%) |
| Sep 2021 | - | $6.67M(+4.8%) | $25.77M(+0.6%) |
| Jun 2021 | - | $6.36M(+0.7%) | $25.61M(+5.6%) |
| Mar 2021 | - | $6.32M(-1.5%) | $24.25M(+3.1%) |
| Dec 2020 | $23.52M(+7.3%) | $6.42M(-1.3%) | $23.52M(+3.8%) |
| Sep 2020 | - | $6.50M(+29.7%) | $22.66M(+4.6%) |
| Jun 2020 | - | $5.01M(-10.2%) | $21.67M(-2.0%) |
| Mar 2020 | - | $5.58M(+0.4%) | $22.11M(+0.9%) |
| Dec 2019 | $21.92M(+7.9%) | $5.56M(+0.9%) | $21.92M(+1.0%) |
| Sep 2019 | - | $5.51M(+1.0%) | $21.70M(+1.3%) |
| Jun 2019 | - | $5.45M(+1.1%) | $21.42M(+2.2%) |
| Mar 2019 | - | $5.39M(+1.0%) | $20.95M(+3.1%) |
| Dec 2018 | $20.32M(+21.9%) | $5.34M(+2.1%) | $20.32M(+3.2%) |
| Sep 2018 | - | $5.23M(+4.8%) | $19.68M(+2.6%) |
| Jun 2018 | - | $4.99M(+5.0%) | $19.19M(+0.8%) |
| Mar 2018 | - | $4.75M(+1.0%) | $19.03M(+14.2%) |
| Dec 2017 | $16.67M | $4.71M(-0.5%) | $16.67M(+22.0%) |
| Sep 2017 | - | $4.73M(-2.1%) | $13.66M(+31.7%) |
| Jun 2017 | - | $4.84M(+102.6%) | $10.38M(+45.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | $2.39M(+40.1%) | $7.12M(+10.4%) |
| Dec 2016 | $6.45M(-9.3%) | $1.71M(+17.7%) | $6.45M(-0.4%) |
| Sep 2016 | - | $1.45M(-8.4%) | $6.47M(-4.5%) |
| Jun 2016 | - | $1.58M(-7.9%) | $6.78M(-3.0%) |
| Mar 2016 | - | $1.72M(-0.8%) | $6.98M(-1.8%) |
| Dec 2015 | $7.11M(-7.2%) | $1.73M(-1.3%) | $7.11M(-2.4%) |
| Sep 2015 | - | $1.75M(-2.0%) | $7.28M(-1.8%) |
| Jun 2015 | - | $1.79M(-2.9%) | $7.41M(-1.8%) |
| Mar 2015 | - | $1.84M(-3.2%) | $7.55M(-3.4%) |
| Dec 2014 | $7.66M(+15.0%) | $1.90M(+1.0%) | $7.81M(+7.8%) |
| Sep 2014 | - | $1.88M(-2.2%) | $7.25M(-0.1%) |
| Jun 2014 | - | $1.92M(-8.7%) | $7.26M(+0.1%) |
| Mar 2014 | - | $2.11M(+57.8%) | $7.25M(+8.8%) |
| Dec 2013 | $6.66M(+268.6%) | $1.33M(-29.4%) | $6.66M(+17.5%) |
| Sep 2013 | - | $1.89M(-1.1%) | $5.67M(+33.9%) |
| Jun 2013 | - | $1.91M(+26.0%) | $4.23M(+50.5%) |
| Mar 2013 | - | $1.52M(+342.9%) | $2.81M(+55.6%) |
| Dec 2012 | $1.81M(-62.2%) | $343.00K(-24.8%) | $1.81M(-17.0%) |
| Sep 2012 | - | $456.00K(-7.7%) | $2.18M(-17.3%) |
| Jun 2012 | - | $494.00K(-3.9%) | $2.63M(-6.5%) |
| Mar 2012 | - | $514.00K(-27.8%) | $2.81M(-41.2%) |
| Dec 2011 | $4.78M(+20.7%) | $712.00K(-21.8%) | $4.78M(-12.3%) |
| Sep 2011 | - | $910.00K(+34.6%) | $5.45M(-3.0%) |
| Jun 2011 | - | $676.00K(-72.8%) | $5.62M(-3.6%) |
| Mar 2011 | - | $2.48M(+79.5%) | $5.83M(+41.1%) |
| Dec 2010 | $3.96M(+9.9%) | $1.38M(+28.3%) | $4.13M(-23.0%) |
| Sep 2010 | - | $1.08M(+21.4%) | $5.36M(+12.7%) |
| Jun 2010 | - | $887.00K(+13.1%) | $4.75M(+22.9%) |
| Mar 2010 | - | $784.00K(-70.0%) | $3.87M(+25.4%) |
| Dec 2009 | $3.60M(+3.2%) | $2.61M(+454.8%) | $3.08M(+554.8%) |
| Sep 2009 | - | $471.00K | $471.00K |
| Dec 2008 | $3.49M | - | - |
FAQ
- What is Pacira BioSciences annual interest expense?
- What is the all time high annual interest expense for Pacira BioSciences?
- What is Pacira BioSciences annual interest expense year-on-year change?
- What is Pacira BioSciences quarterly interest expense?
- What is the all time high quarterly interest expense for Pacira BioSciences?
- What is Pacira BioSciences quarterly interest expense year-on-year change?
- What is Pacira BioSciences TTM interest expense?
- What is the all time high TTM interest expense for Pacira BioSciences?
- What is Pacira BioSciences TTM interest expense year-on-year change?
What is Pacira BioSciences annual interest expense?
The current annual interest expense of PCRX is $13.44M
What is the all time high annual interest expense for Pacira BioSciences?
Pacira BioSciences all-time high annual interest expense is $35.58M
What is Pacira BioSciences annual interest expense year-on-year change?
Over the past year, PCRX annual interest expense has changed by -$3.87M (-22.36%)
What is Pacira BioSciences quarterly interest expense?
The current quarterly interest expense of PCRX is $3.73M
What is the all time high quarterly interest expense for Pacira BioSciences?
Pacira BioSciences all-time high quarterly interest expense is $9.64M
What is Pacira BioSciences quarterly interest expense year-on-year change?
Over the past year, PCRX quarterly interest expense has changed by +$1.10M (+41.75%)
What is Pacira BioSciences TTM interest expense?
The current TTM interest expense of PCRX is $14.54M
What is the all time high TTM interest expense for Pacira BioSciences?
Pacira BioSciences all-time high TTM interest expense is $35.62M
What is Pacira BioSciences TTM interest expense year-on-year change?
Over the past year, PCRX TTM interest expense has changed by +$3.25M (+28.74%)